Goodman Financial’s Idexx Laboratories IDXX Stock Holding History

Goodman Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-422	Closed	-$211K	–	47
2023 Q1	$211K	Buy	+422	New	+$202K	0.06%	49

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Goodman Financial's IDXX Position: Q2 2023 in Review

Goodman Financial sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 422 shares — an estimated $211K sold.

Goodman Financial first reported a position in IDXX in Q1 2023 and held it in 1 quarter. The position peaked at $211K in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Goodman Financial reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Goodman Financial sold 422 Idexx Laboratories shares in Q2 2023, an estimated $211K.
Goodman Financial first reported a position in Idexx Laboratories in Q1 2023 and held it in 1 quarter.
Goodman Financial's Idexx Laboratories position peaked at $211K in Q1 2023.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Goodman Financial's 13F filing for Q2 2023, filed 8 Aug 2023.